Newton Biocapital
Venture capital firm focused on early-stage life sciences companies targeting chronic health conditions
📍 Brussels, Belgium
About This Fund
Venture capital firm focused on early-stage life sciences companies targeting chronic health conditions. It is a hands-on investor that leverages its expertise to help its portfolio companies focus on the right indication and clinical trial design.
Investment Focus
Sectors
Stages
Check Size
$3.4M-$11.5M
Geography
What They Look For
European (Belgium, France, Netherlands, Germany) and Japanese biotech startups and spin-offs; promising solutions in chronic health conditions; strong scientific teams from academic centers
Preparing to pitch Newton Biocapital?
CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.
Analyze My Deck →